Delivery Order SPE2DB22D1202-SPE2DB25FVJS7
- Not listed
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $1,362.06 by the Defense Logistics Agency on August 12, 2025, for the supply of Tenivac syringes in 0.5 mL quantities. The contract is a firm fixed price delivery order with an ultimate completion date of August 13, 2025, and represents a non-competitive set-aside award. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,180.40 to AmerisourceBergen Drug Corp for the supply of Tenivac syringes (0.5mL) on August 22, 2025, with an ultimate completion date of August 25, 2025. This firm fixed-price delivery order represents a non-set-aside competitive award with a place of performance in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,135.05 to AmerisourceBergen Drug Corp for the supply of Tenivac syringes (0.5 mL) under a firm fixed-price contract. The order, issued on August 22, 2025, with an ultimate completion date of August 25, 2025, represents a competitively awarded non-set-aside contract. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location in Conshohocken, PA 19428. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of TENIVAC syringes (0.5mL) under a firm fixed-price contract valued at $6,779.54. The contract, which was competitively awarded with no set-aside designation, has an ultimate completion date of August 8, 2025. AmerisourceBergen's corporate office in Conshohocken, Pennsylvania served as the place of performance for this order. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Tenivac syringes (0.5mL) valued at $1,135.05 on July 29, 2025, with a completion date of July 30, 2025. This competitively awarded, firm fixed-price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The place of performance is AmerisourceBergen's...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor based in Conshohocken, Pennsylvania, has been awarded a $3,270.07 delivery order by the Defense Logistics Agency for TENIVAC Syringe 0.5ML medical supplies. The contract, issued on August 15, 2025, utilizes firm fixed-price pricing with an ultimate completion date of August 18, 2025. This award is a non-set-aside, competitively awarded delivery order issued under AmerisourceBergen's existing contract vehicle with DLA. This...
- The Defense Logistics Agency awarded a $1,135.05 firm fixed price delivery order to AmerisourceBergen Drug Corp on August 5, 2025, for TENIVAC syringes in 0.5ML quantities, with performance completion scheduled for August 6, 2025. This non-set-aside contract represents a routine medical supply procurement executed through AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive $999,999,999.00 pharmaceutical support vehicle valued...
- The Defense Logistics Agency awarded a delivery order valued at $18,881.66 to AmerisourceBergen Drug Corp for the supply of TENIVAC vials (0.5ML) on July 29, 2025, with an ultimate completion date of July 30, 2025. This firm fixed-price delivery order represents a non-set-aside competitive award, with performance to be executed from the contractor's location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Tenivac Syringes 0.5ML. The contract has a firm fixed price of $1,865.28 and a period of performance through April 2025. It is not designated as a set-aside contract, indicating open competition. AmerisourceBergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00, which...
- This is a $1,302.54 firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The contract is for the supply of 4565305627 TENIVAC SYRINGE 0.5ML, a vaccine product. The order has an ultimate completion date of August 1, 2024. AmerisourceBergen holds an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999 through December 2025, which serves as a primary...
- SPE2DB22D1202Indefinite Delivery Contract
- SPE2DB22D1202-SPE2DB25FVJS7Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 28, 2025, for the supply of Tenivac syringes (0.5ml) under a firm fixed-price contract valued at $1,816.08. The order represents a non-set-aside competitive award with an ultimate completion date of August 29, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (designated SPE2DX), a $999.9 billion prime vendor agreement running through December 2026 that provides comprehensive pharmaceutical and medical supply support to military healthcare programs worldwide. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that serves as a critical vendor for federal medical procurement, particularly supporting Defense Health Agency and military healthcare systems. The company maintains an extensive portfolio of federal contract awards with DLA for a wide spectrum of pharmaceutical products, medical devices, vaccines, and specialized healthcare commodities across multiple therapeutic domains. This specific delivery order for syringes reflects the company's ongoing role in supplying essential medical commodities that support military medical operations and readiness requirements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.8k | 8/28/25 |